Embedded Files
Clinical Insights & Basic Science
MARCH 23, 2018
DELHI
About the Meeting
About the Meeting
The meeting would discuss scientific and clinical advances of hemoglobinopathies. This would include disease mechanisms, new therapeutic strategies, and targets as well as potential curative therapies including bone-marrow transplantation, gene therapy and genome editing approaches.
The meeting would also enable close interaction between clinicians and scientists working in the area towards creating collaborative translational efforts in India
Speakers
Speakers
- Prof. Alok Srivastava (Christian Medical College, Vellore)
- Prof. Renu Saxena (All India Institute of Medical Sciences, Delhi)
- Prof. KP Aravindan (Govt Medical College, Kozhikode)
- Dr. Suman Jain (Thalassemia and Sickle Cell Society, Hyderabad)
- Dr. Neerja Gupta (All India Institute of Medical Sciences, Delhi)
- Dr Sivaprakash Ramalingam (CSIR-IGIB, Delhi)
- Dr. Chetana Sachidanandan (CSIR-IGIB, Delhi)
- Dr. Revathy Raj (Apollo Hospital, Chennai) TBC.
- Prof. Dipty Jain (Nagpur Medical College, Nagpur)
- Dr. Roshan Colah (National Institute of Immunohematology, Mumbai)
- Prof. Anjana Munshi (Central University of Punjab)
- Dr. Sujatha Mohanty (All India Institute of Medical Sciences, Delhi)
- Dr. S Rajasubramaniam (National Institute for Research in Tribal Health, Jabalpur)
*TBC: To Be Confirmed
Translational Research programmes on Hemoglobinopathies at CSIR-IGIB
Translational Research programmes on Hemoglobinopathies at CSIR-IGIB
Translational Research on Sickle Cell Anemia
Translational Research on Sickle Cell Anemia
Researchers at CSIR-IGIB are involved in a variety of programmes including genetic epidemiology, genome-editing and chemical biology approaches focused on Sickle Cell Anemia. We are a participant in the CSIR Mission Programme on Sickle Cell Anemia.
Efficient Fe Control in Thalassemics (EFeCT)
Efficient Fe Control in Thalassemics (EFeCT)
Through in vivo drug screens we have identified drugs that can modulate the iron regulatory hormone, hepcidin. The Efficient Fe Control in Thalassemics (EFeCT) aims to repurpose drugs for reducing iron overload in Thalassemia.
more at: https://goo.gl/k4XvnH
Genetic Charecterisation of Hemoglobinopathies
Genetic Charecterisation of Hemoglobinopathies
The Genomics and other omics technologies for Enabling Medical Decisions (GOMED) offers geentic screening for prevalent Hemoglobinopathies including Thalassemia, Sickle Cell Anemia and other rarer forms of Hemoglobin disorders.
more at http://gomed.igib.in
Venue
Venue
CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB)
CSIR-Institute of Genomics & Integrative Biology (IGIB) is a premier Institute of Council of Scientific and Industrial Research (CSIR), engaged in research of national importance in the areas of genomics, molecular medicine, bioinformatics, proteomics and environmental biotechnology.
Support / Funding / SPONSORS
Support / Funding / SPONSORS
We acknowledge financial support from the Council of Scientific and Industrial Research (CSIR), India through Mission programme on Sickle Cell Anemia (HCP008)
Report abuse